MedPath

Breast tumor imaging using ultrasound

Not yet recruiting
Conditions
Imaging,
Registration Number
CTRI/2023/07/054888
Lead Sponsor
Indian Institute of Technology Hyderabad
Brief Summary

The study aims to advance our understanding of the role of ultrasound imaging in quantifying the heterogeneity of breast tumors (across different sub-types) and its correlation with immunohistochemistry, 2D/3D mammography, and potential therapeutic response.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients consenting to participate in the study 2.
  • Age 18 or above 3.
  • Adequate clinical parameters for breast tumor ultrasound imaging 5.
  • Ability to maintain a supine position during the study.
Exclusion Criteria
  • Pregnant or currently lactating female participants 2.
  • Significant renal or hepatic impairment 3.
  • Uncontrolled illness or medical conditions that hinder ultrasound imaging 4.
  • Skin ulceration or issues affecting the proper placement of ultrasound transducer 5.
  • Inability to tolerate required position or procedure during the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Collect 2D/3D images (B-mode & shear wave elastography) of breast tumors using ultrasound to assess the heterogeneity of breast tumors.First clinical visit
Secondary Outcome Measures
NameTimeMethod
1.Acquire 2D/3D ultrasound images of breast tumors using techniques such as B-mode imaging & color Doppler imaging.2.Establish correlations between ultrasound measurements & mammographic data, immunohistochemistry (IHC) results, additional imaging modalities, clinical information, disease stage, treatment response, and clinical outcomes.

Trial Locations

Locations (1)

Chennai Breast Center

🇮🇳

Chennai, TAMIL NADU, India

Chennai Breast Center
🇮🇳Chennai, TAMIL NADU, India
Avinash Eranki
Principal investigator
9986820250
aeranki@bme.iith.ac.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.